Genetic Technologies Ltd. Shares Up 36% Premarket After Co. Announced Breast And Colorectal Cancer Tests To Launch In October; Co. Also Expects Melanoma, Prostate Cancer, Type 2 Diabetes And Cardiovascular Disease Tests To Be Available Over Next 12 Months
Benzinga Newsdesk